Free-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor

Roxana G. Burciu, Edward Ofori, Priyank Shukla, Ofer Pasternak, Jae Woo Chung, Nikolaus R. McFarland, Michael S. Okun, David E. Vaillancourt

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Rasagiline is a monoamine oxidase type B inhibitor that possesses no amphetamine-like properties, and provides symptomatic relief in early and late stages of Parkinson's disease (PD). Data in animal models of PD suggest that chronic administration of rasagiline is associated with structural changes in the substantia nigra, and raise the question whether the structure and function of the basal ganglia could be different in PD patients treated chronically with rasagiline as compared with PD patients not treated with rasagiline. Here, we performed a retrospective cross-sectional magnetic resonance imaging (MRI) study at 3 T that investigated nigrostriatal function and structure in PD patients who had taken rasagiline before testing (∼8 months), PD who had not taken rasagiline before testing, and age-matched controls. The two PD groups were selected a priori to not differ significantly in age, sex, disease duration, severity of symptoms, cognitive status, and total levodopa equivalent daily dose of medication. We evaluated percent signal change in the posterior putamen during force production using functional MRI, free-water in the posterior substantia nigra using diffusion MRI, and performance on a bimanual coordination task using a pegboard test. All patients were tested after overnight withdrawal from antiparkinsonian medication. The rasagiline group had greater percent signal change in the posterior putamen, less free-water in the posterior substantia nigra, and better performance on the coordination task than the group not taking rasagiline. These findings point to a possible chronic effect of rasagiline on the structure and function of the basal ganglia in PD. Hum Brain Mapp, 2016. © 2016 Wiley Periodicals, Inc.
Original languageEnglish (US)
Pages (from-to)2894-2903
Number of pages10
JournalHuman Brain Mapping
DOIs
StatePublished - Aug 1 2016

Keywords

  • Parkinson's disease
  • free-water diffusion MRI
  • nigrostriatal regions
  • rasagiline
  • task-based fMRI

Fingerprint Dive into the research topics of 'Free-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor'. Together they form a unique fingerprint.

Cite this